This novel Aurora-A/NF-κB/miR-21/PTEN axis provides new insight into the mechanisms underlying HCC chemoresistance, and target this signaling pathway may be a potential therapeutic strategy for chemosensitization of HCC in the future. Here, PTEN is linked to hepatocellular carcinoma.